Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-17
2007-04-17
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000, C548S236000
Reexamination Certificate
active
10465427
ABSTRACT:
The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5′-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases.
REFERENCES:
patent: 2464597 (1949-03-01), McQueen
patent: 3511804 (1970-05-01), Duennenberger et al.
patent: 4119783 (1978-10-01), Hall et al.
patent: 4686234 (1987-08-01), Nelson et al.
patent: 4725622 (1988-02-01), Nelson et al.
patent: 4727069 (1988-02-01), Nelson et al.
patent: 4753935 (1988-06-01), Nelson et al.
patent: 4786637 (1988-11-01), Allison et al.
patent: 4808592 (1989-02-01), Nelson et al.
patent: 4861776 (1989-08-01), Nelson et al.
patent: 4861791 (1989-08-01), Diana et al.
patent: 4868153 (1989-09-01), Allison et al.
patent: 4948793 (1990-08-01), Allison et al.
patent: 4952579 (1990-08-01), Nelson et al.
patent: 4959387 (1990-09-01), Nelson et al.
patent: 4992467 (1991-02-01), Allison et al.
patent: 5073562 (1991-12-01), Djuric et al.
patent: 5247083 (1993-09-01), Knox et al.
patent: 5334604 (1994-08-01), Goldstein et al.
patent: 5380879 (1995-01-01), Sjogren
patent: 5444072 (1995-08-01), Patterson et al.
patent: 5665583 (1997-09-01), Collart et al.
patent: 5807876 (1998-09-01), Armistead et al.
patent: 6207697 (2001-03-01), Han et al.
patent: 6344450 (2002-02-01), Bisacchi et al.
patent: 1127883 (2001-08-01), None
patent: 08/92223 (1996-04-01), None
patent: WO94/01105 (1994-01-01), None
patent: WO94/12184 (1994-06-01), None
patent: WO-97/10228 (1997-03-01), None
patent: WO 97/24343 (1997-07-01), None
patent: WO97/40028 (1997-10-01), None
patent: WO98/40381 (1998-09-01), None
patent: WO99/55663 (1999-11-01), None
patent: WO 99/65897 (1999-12-01), None
Nature 256:331-333 (1975) Jackson et al.
J. Biol.Chem. 263:15769-15662 (1988) Collart et al.
J. Biol.Chem. 265:5292-5295 (1990) Natsumeda et al.
J. Biol.Chem. 266:506-509 (1991) Weber.
J. Biol.Chem. 268:27286-27290 (1993) Carr.
Hall, I. H., et al.; Anti-Cancer Drugs, vol. 3, No. 3, pp. 273-280, 1992.
Cooper, K., et al.; J. Med. Chem. vol. 35, pp. 3115-3129, 1992.
Abstract—Database Caplus, Chem. Abst. Service, (XP-002399025), 1965.
Abstract—Database Beilstein, (XP-002399026), 1992.
Dhar T. G. Murali
Gu Henry H.
Iwanowicz Edwin J.
Bristol--Myers Squibb Company
Duncan Laurelee A.
Stockton Laura L.
LandOfFree
Inhibitors of IMPDH enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of IMPDH enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of IMPDH enzyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3748801